• 1
    Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol. 2002; 167(2 Pt 1): 528534.
  • 2
    Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol. 2000; 164: 19291934.
  • 3
    McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol. 1992; 23(3): 258266.
  • 4
    Eastham JA, Scardino PT. Early diagnosis and treatment of prostate cancer. Dis Mon. 2001; 47(9): 421459.
  • 5
    Rosen MA, Goldstone L, Lapin S, Wheeler T, Scardino PT. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. J Urol. 1992; 148(2Pt 1): 331337.
  • 6
    Kim ED, Nath R, Kadmon D, et al. Bilateral nerve graft during radical retropubic prostatectomy: 1-year followup. J Urol. 2001; 165(6 Pt 1): 19501956.
  • 7
    Sofer M, Hamilton-Nelson KL, Schlesselman JJ, Soloway MS. Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. J Clin Oncol. 2002; 20(7): 18531858.
  • 8
    D'Amico AV, Whittington R, Malkowicz SB, et al. Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure. Urology. 1997; 49(3A Suppl ): 2330.
  • 9
    D'Amico AV, Whittington R, Malkowicz SBE, et al. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status, and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer. J Clin Oncol. 1996; 14: 17701777.
  • 10
    Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology. 1997; 202: 697702.
  • 11
    Ikonen S, Karkkainen P, Kivisaari L, et al. Magnetic resonance imaging of clinically localized prostatic cancer. J Urol. 1998; 159: 915919.
  • 12
    Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology. 1999; 213: 481488.
  • 13
    Ogura K, Maekawa S, Okubo K, et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology. 2001; 57(4): 721726.
  • 14
    Tempany CM, Rahmouni AD, Epstein JI, Walsh PC, Zerhouni EA. Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging. Radiology. 1991; 181: 107112.
  • 15
    Han M, Walsh PC, Partin AW, Rodriguez R. Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease. J Urol. 2000; 164: 8992.
  • 16
    Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001; 58: 843848.
  • 17
    Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997; 277: 14451451.
  • 18
    Eastham JA, Scardino PT: Radical prostatectomy for clinical stage T1 and T2 prostate cancer. In: VogelzangNJ, ScardinoPT, ShipleyWU, CoffeyDS, editors. Comprehensive textbook of genitourinary oncology. 2nd edition. Philadelphia: Lippincott Williams and Wilkins, 2000: 722.
  • 19
    Yossepowitch O, Engelstein D, Konichezky M, Sella A, Livne PM, Baniel J. Bladder neck involvement at radical prostatectomy: positive margins or advanced T4 disease. Urology. 2000; 56(3): 448452.
  • 20
    McCulloch CE, Searle SR. Generalized, linear, and mixed models. New York: John Wiley & Sons, 2001.
  • 21
    Coakley FV, Kurhanewicz J, Lu Y, et al. Prostate cancer tumor volume: measurement by endorectal MR imaging and MR spectroscopic imaging. Radiology. 2002; 223(1): 9197.
  • 22
    Rifkin MD, Zerhouni EA, Gatsonis CA, et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med. 1990; 323(10): 621626.
  • 23
    Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging – clinicopathologic study. Radiology. 1999; 213: 473480.
  • 24
    D'Amico AV, Whittington R, Malkowicz B, et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol. 2000; 164: 759763.
  • 25
    Cornud F, Flam T, Chauveinc L, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology. 2002; 224(1): 203210.
  • 26
    Tempany CM, Zhou X, Zerhouni EA, et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology. 1994; 192: 4754.
  • 27
    Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step-section histology. J Urol. 2000; 164: 400404.
  • 28
    Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer. 1997; 79: 528537.
  • 29
    Blute ML, Bergstralh EJ, Partin AW, et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol. 2000; 164: 15911595.